GSK added Ojjaara to its portfolio through the acquisition of Sierra in 2022. Credit: Magda Wygralak via Shutterstock. Health ...

Approximately 44 million COPD cases were recorded in 2023 in the 7MM, expected to grow at a 1.4% CAGR through 2034. After ...

Sun Pharmaceuticals Industries Ltd. also demonstrated strong performance at 13.1% ... Ltd. (8.6%), Alkem Laboratories Ltd. (7 ...

Saudi Arabia Pharmaceutical Drugs Market is estimated to be valued at US$ 12.60 billion in 2024 and is expected to exhibit a CAGR of 7.6% by 2031 BURLINGAME, CA, UNITED STATES, November 12, 2024 ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

GSK celebrates 100 years in India with former MDs, highlighting resilience and reinvention in the pharmaceutical industry.

Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...

Andrew Witty became CEO of UnitedHealth Group in 2021, but this isn’t his first medical executive gig—he also served as CEO ...

Zealand Pharmaceuticals, Zeria; has received research support from Biohit, Kiowa Kirin, ProMed, Sofar, Takeda and Tsumura and ...